Read + Share
. Correction to: Efpeglenatide and Clinical Outcomes With and Without Concomitant
Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory
Analysis of the AMPLITUDE-O Trial. Circulation 2023;147:e720.
PMID: 37276255
|
 |
|
